CTRI/2015/10/006287
Other
未知
A Multicenter prospective community based surveillance to estimate the burden of rotavirus gastroenteritis in children â?¤ 24 months of age in India
Shantha Biotechnics PvtLtd0 sites3,000 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Shantha Biotechnics PvtLtd
- Enrollment
- 3000
- Status
- Other
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Children \<\= 24 months presenting to Out Patient Department/Emergency with acute diarrhea requiring hospitalization for minimum 6 hours.
- •Parents/Legally Acceptable Representative willing to sign ICF for inclusion in the study.
Exclusion Criteria
- •Non\-resident or not belonging to the predefined population study base
- •Subject reporting to hospital with an episode of diarrhea with onset more than 14 days
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A Multicenteric study to estimate the burden of rotavirus gastroenteritis among hospitalization due to diarrhea.Health Condition 1: null- Hospital-based surveillance of rotavirus gastroenteritis in children â?¤ 59 months of ageCTRI/2012/03/002475Shantha Biotechnics Limited2,000
Completed
Not Applicable
Multicenter Prospective Observational Registry of DeliriumDeliriumJPRN-UMIN000032646Japan Society of Clinical Research100
Completed
Not Applicable
A study to asses causes of death in rural villagesHealth Condition 1: null- All-age deaths occuring in 2014-2015 in 50 villages of Devanahalli taluk.CTRI/2018/02/011892bangalore baptist hospital202
Enrolling By Invitation
Not Applicable
PUER ("Previously Unrecognized Emerging Risks") Life Clinical StudyAgingNCT05687578Puer Research, LLC10,000
Completed
Not Applicable
An Observational prospective Multicenter registry study on Outcomes of peripheral arTErial disease patieNts treated by AngioplaSty tHerapy in aortoIliac arteryPeripheral artery diseaseJPRN-UMIN000013849Research group on endovascular treatment in aortiliac artery1,500